Cingulate Inc. (CING) intrinsic value & 10-year financials
Cingulate Inc. (CING) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $4.36
- Market cap
- $22.0M
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- -155.1%
- Free cash flow (FY2025)
- -$17.4M
CING 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$22.4M | -$4.44 | -$17.4M | — | 305.7% |
| FY2024 | — | -$15.5M | -$10.20 | -$18.7M | — | 229.1% |
| FY2023 | — | -$23.5M | -$26.00 | -$15.3M | — | 607.3% |
| FY2022 | — | -$17.7M | -$29.35 | -$16.0M | — | -831.3% |
| FY2021 | — | -$20.7M | — | -$11.2M | — | -645.0% |
| FY2020 | — | -$7.2M | — | -$7.2M | — | -596.2% |
| FY2019 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Cingulate Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Cingulate Inc. has historically struggled to out-earn its cost of capital, averaging just -1.6% ROIC.
Cingulate Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Cingulate Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.